Russian scientist succeeded in developing an anti-cancer vaccine that prolongs patient’s life.
In the Scientific Research Institute of Immunology at the Siberian department of the Russian Academy, scientists created a vaccine that was successful in passing all clinical researches and showed really good results.
The anti-cancer vaccine
The patients diagnosed with cancer, were given the vaccine in the third or fourth stage of their disease, which prolonged their life for more than 2 times.
The next phase includes applying the vaccine in the early stages, reports the Voice of Russia.
“When the vaccine was first given to patients in the third or fourth stage of diseases like prostate and breast cancer, the treatment significantly prolonged their life”, says Vladimir Kozlov, the leader of the research conducted at the Institute of immunology.
The vaccine can be used for treating various cancer types like: colon, breast, and prostate cancer. The vaccine was ready for commercial production, according to the report of the Institute.
The innovation’s primary application in the Russian and CIS markets will be treatment of renal cell carcinoma. However, clinical trials conducted in Russia, the U.S. and Europe have also reportedly proved Oncophage’s validity for a range of multiple cancers, including melanoma, glioma, colorectal cancer, pancreatic cancer, gastrointestinal tract cancer, and non-Hodgkin’s lymphomas.